Study reports algorithm for autosegmentation of brain tumor images | Scientists study how brain processes language, speech timing | Siemens Healthcare subsidiary to distribute prostate tracer
 
May 22, 2015
CONNECT WITH SNMMI LinkedInFacebookTwitterYoutube
SNMMI SmartBrief
News for nuclear medicine and molecular imaging professionals
SIGN UP|FORWARD|ARCHIVE|ADVERTISE

Top Story
Study reports algorithm for autosegmentation of brain tumor images
An algorithm designed for segmentation of tumor data "is robust to variation in image quality and tumor type," researchers wrote in Academic Radiology. Many approaches have been tried to allow automated segmentation, but none has yielded a perfect solution. The new technique is effective regardless of noise, differences in equipment and other variation, the study found. AuntMinnie.com (free registration) (5/22)
Share: LinkedInTwitterFacebookGoogle+Email
Want to Be a Better Salesperson? Build Relationships
Today's knowledge-hungry consumers often know as much about a product as the people trying to sell it. So what's your sales edge? Learning to build stronger relationships with your clients. Read the featured article.
Advertisement

Clinical News & Research
Scientists study how brain processes language, speech timing
Researchers studying how the human brain processes spoken language say they have identified an area that is sensitive to time structures in speech. Data from functional magnetic resonance imaging revealed more activity in the superior temporal sulcus region when participants heard longer speech segments. Medical News Today (5/19)
Share: LinkedInTwitterFacebookGoogle+Email
Industry Report
Siemens Healthcare subsidiary to distribute prostate tracer
Siemens' PETNET Solutions will manufacture and distribute F-18 fluciclovine in the U.S., under an agreement with Blue Earth Diagnostics, if the PET/CT tracer is approved by the FDA. The tracer is designed for prostate imaging. HealthImaging.com (5/21), AuntMinnie.com (free registration) (5/21)
Share: LinkedInTwitterFacebookGoogle+Email
Radiation dose technology company gets U.S. patent
A U.S. patent was granted for the wireless molecular sensor system and process developed by VeriTeQ. The company will initially use the system to design tools to measure radiation doses during cancer treatment. AuntMinnie.com (free registration) (5/21)
Share: LinkedInTwitterFacebookGoogle+Email
News from the Field
EHR incentives exceed $30B as of March
The CMS has released Medicaid and Medicare EHR incentive payments totaling over $30 billion to 447,842 eligible hospitals and professionals as of March. Around $3.6 billion was given to qualified Medicaid professionals, $7.7 billion went to qualified Medicare professionals, eligible hospitals nabbed $18.3 billion and Medicare Advantage groups received $400 million. BeckersHospitalReview.com (5/21)
Share: LinkedInTwitterFacebookGoogle+Email
Health Policy
House panel OKs 21st Century Cures measure
The 21st Century Cures bill passed the House Energy and Commerce Committee in a 51-0 vote Thursday. The bill would speed up drug approval by requiring the FDA to improve its drug review process, look at more flexible forms of clinical studies and include patient experience in the decision-making process. The full House is expected to vote on the measure in June. The Hill (5/21), Reuters (5/21)
Share: LinkedInTwitterFacebookGoogle+Email
CMS drafts coverage of prostate cancer test from Genomic Health
A CMS contractor has released a local coverage determination draft for Genomic Health's Oncotype DX test for prostate cancer. The draft would allow coverage of the test when used to identify biopsy-confirmed early-stage prostate cancer patients who are candidates for surveillance, rather than radiation therapy or surgery. GenomeWeb Daily News (free registration) (5/21)
Share: LinkedInTwitterFacebookGoogle+Email
Advancing Health Care
Can social support improve home monitoring of blood pressure?
A clinical trial will be launched by the University of Pennsylvania to determine whether social incentives could boost blood pressure monitoring adherence in patients with a history of uncontrolled hypertension and cerebral infarction. Control group participants will receive automated alerts when they fail to check their blood pressure, while participants in the test group will have a person offer social support to ensure monitoring occurs. When checks are missed, the patient and supporter will receive alerts. MobiHealthNews.com (5/21)
Share: LinkedInTwitterFacebookGoogle+Email
From SNMMI
Available on-demand: Radiation Safety in SPECT/CT and PET/CT webinar
This popular quarterly SNMMI-TS webinar sold out quickly. Now, you can view the "Radiation Safety in SPECT/CT and PET/CT" webinar on-demand. Presenter Cybil Nielsen, MBA, CNMT, FSNMMI-TS, will lead you through identifying additional radiation safety concerns with hybrid imaging, estimating patient doses for various SPECT/CT and PET/CT exams and describing how to apply ALARA principles for occupational exposure when performing hybrid imaging. Please note: This webinar is complimentary for SNMMI Members. Get started.
Share: LinkedInTwitterFacebookGoogle+Email
Order the top-selling Quick Reference Protocol Manual for Nuclear Medicine Technologists
Grab your copy of this popular new book from SNMMI. Targeting technologists specifically, the new Quick Reference Protocol Manual for Nuclear Medicine Technologists provides structured, up-to-date information for more than 70 nuclear medicine procedures. Each protocol lists the essential information for the procedure, from patient preparation through dose and administration. Learn more and order your copy today!
Share: LinkedInTwitterFacebookGoogle+Email
Editor's Note
SmartBrief will not publish Monday
SmartBrief will not publish Monday in observance of Memorial Day in the U.S. Publication will resume Tuesday.
Share: LinkedInTwitterFacebookGoogle+Email
SmartQuote
Rank does not confer privilege or give power. It imposes responsibility."
-- Peter Drucker,
management consultant and writer
Share: LinkedInTwitterFacebookGoogle+Email
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items above are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Melissa Turner
Advertising:  Meryl Harold
  P: 202.407.7828
 
 

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information